Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Heart (British Cardiac Society)|January 3, 2006
Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic studyP-V Ennezat, B Gal, C Kouakam, et al.
Physical Review Letters|September 28, 2004
Fine structure in the energy region of the isoscalar giant quadrupole resonance: characteristic scales from a wavelet analysisA Shevchenko, J Carter, R W Fearick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2022
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatinR Iacovelli, C Ciccarese, M Brunelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 1, 2008
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney diseaseDawei Xie, Marshall M Joffe, Steven M Brunelli, et al.
BMC Nephrology|April 4, 2014
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysisMitesh Shah, Arsh K Jain, Steven M Brunelli, et al.
Diabetes & Metabolism|October 6, 2018
Cardiometabolic assessment of lamin A/C gene mutation carriers: a phenotype-genotype correlationM Kwapich, D Lacroix, S Espiard, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 24, 2024
Malformations of Cortical Development: Updated Imaging ReviewJulia M Brunelli, Thiago J P Lopes, Isabela S Alves, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
ESMO Open|December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access ProgramS E Rebuzzi, A Signori, S Buti, et al.
Pageof 35